欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/V/0244/001
药品名称Rispoval IBR-Marker+BRSV+PI3 vivum
活性成分
    • Bovine parainfluenza 3 virus attenuated 2.0 ml
    • Bovine Respiratory Syncytial Virus (BRSV), strain 375 attenuated attenuated 2.0 ml
    • Infectious Bovine Rhinotracheitis Virus attenuated 2.0 ml
剂型Suspension for injection
上市许可持有人Pfizer Limited Sandwich, Kent CT13 9NJ United Kingdom
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Belgium (BE)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
      RISPOVAL IBR+MARKER+RS+PI3 VIVUM
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
      Rispoval IBR-Marker+BRSV+PI3 vivum
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
      RISPOVAL IBR-Marker+BRSV+Pi3 Vivum
许可日期2007/07/25
最近更新日期2021/01/04
药物ATC编码
    • QI02AD Live viral vaccines
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase